Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs032180188
JPRN-jRCTs032180188
Completed
Phase 2

Development of a new transcranial magnetic stimulation therapy for treatment-resistant depression and identification of its predictor of response - TRD-rTMS longitudinal Study

oda Yoshihiro0 sites180 target enrollmentMarch 6, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTreatment Resistance Depression

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Treatment Resistance Depression
Sponsor
oda Yoshihiro
Enrollment
180
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
oda Yoshihiro

Eligibility Criteria

Inclusion Criteria

  • •(1\) Outpatients or inpatients of Neuropsychiatry, Keio University Hospital
  • •(2\) 18 years old or over when obtaining consent
  • •(3\) Patient who is able to give a written consent according to an attending physician
  • •(4\) Meeting the diagnostic criteria of Major Depressive disorder based on DSM\-5
  • •(5\) The current episode is scored 3 or greater in ATHF, or nonresponsive to two different kind of antidepressants in the past
  • •(6\) The score 18 or greater MADRS
  • •(7\) Mental condition is stable enough for the examination

Exclusion Criteria

  • •(1\)Patients with organic brain disorder (Moderate or severe intracranial organic lesions or neurodegenerative disease)
  • •(2\) History of seizures and/or epilepsy
  • •(3\) Diagnosis of substance related disorders in the last 6 months
  • •(4\) Serious or unstable physical condition
  • •(5\) Received rTMS or ECT treatment in the last 6 months
  • •(6\) Having contraindications of TMS or MRI, such as metal\-containing objects or a heart pacemaker implanted in the body or claustrophobic
  • •(7\) The size of the head, neck, or body not suitable for MRI devices
  • •(8\) Other cases considered unsuitable for the study by the investigator or collaborating physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Development of a new transcranial magnetic stimulation therapy for treatment-resistant depression and identification of its predictor of responseTreatment-resistant depression(TRD)
JPRN-UMIN000028855Department of Neuropsychiatry, Keio University School of Medicine150
Recruiting
Not Applicable
Transcranial magnetic stimulation (TMS) for the treatment of refractory uncompensated vestibular dysfunction and exploring the optimal technical parameters of TMSVestibular dysfunction
JPRN-UMIN000013556Department of Otolaryngology, Kyorin University School of Medicine20
Completed
Not Applicable
Transcranial magnetic stimulation (TMS) for the treatment of lithium-resistant bipolar depression and exploring the optimal technical parameters of TMSBipolar depression
JPRN-UMIN000007612Department of Neuropsychiatry, Kyorin University School of Medicine50
Active, not recruiting
Not Applicable
Helsinki improved transcranial magnetic stimulation for depressio
ISRCTN46722730Hospital District of Helsinki and Uusimaa80
Recruiting
Not Applicable
Swift Treatment using transcranial magnetic stimulation and Outcome Prediction in DepressioF32F33F31Depressive episodeRecurrent depressive disorderBipolar affective disorder
DRKS00028014niversitätsklinikum der RWTH Aachen44